BIT 5.56% 1.9¢ biotron limited

The Final Countdown, page-54

  1. 13,963 Posts.
    lightbulb Created with Sketch. 2379
    Wonder if the announcement on trial results will be like this Oct 2014 announcement?

    Not much happened after that and BIT is still spruiking that it is doing further trials with HepC. I would have thought that a "cure" makes any further research redundant.

    Biotron shares soar on Hepatitis C trial data

    Australian drug developer Biotron may have found a potential cure for Hepatitis C, after all patients who completed a trial of its lead antiviral drug emerged with undetectable levels of the virus.


    Updated Oct 10, 2014 – 2.59pm,first published at 1.43pm




    Australian drug developer Biotron may have found a potential cure for Hepatitis C.

    Biotron said on Friday that all patients who completed a phase II clinical trial of its lead antiviral drug, BIT225, had undetectable levels of Hepatitis C after ceasing all treatment.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
0.001(5.56%)
Mkt cap ! $17.14M
Open High Low Value Volume
1.8¢ 1.9¢ 1.8¢ $3.69K 197.6K

Buyers (Bids)

No. Vol. Price($)
5 2175000 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 480522 6
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.